Latest S-1 registration statements

Lakewood-Amedex Biotherapeutics seeks a Nasdaq direct listing with a concurrent $7.5m Series C preferred financing and aims to start a Phase 2a trial for lead anti-infective Nu-3.

Figure Technology Solutions, Inc. is offering up to 4.23 million shares of its Series A Blockchain Common Stock and Class A Common Stock, following strong financial performance and a recent recombination of its businesses.

Amaze Holdings, Inc. filed an S-1 registration statement for the resale of up to 50 million shares tied to a $25 million equity line of credit, signaling a strategic shift to its e-commerce platform while facing significant losses and going concern doubts.

Movano Inc. is undergoing a reverse merger with AI cloud computing company Corvex, Inc., shifting its business focus and addressing Nasdaq listing compliance while raising significant capital.

Advasa Holdings, Inc., a fintech company specializing in Earned Wage Access, is preparing for a direct listing on the Nasdaq Global Market, reporting significant revenue and net income growth in its latest interim period.

Climate Transition Special Opportunities SPAC I filed an S-1/A amendment to refile an exhibit and provide updated details on offering expenses, founder shares, and private placement warrants.

Birchtech Corp. files an S-1/A registration statement to offer 4.46 million shares of common stock, seeking a NYSE American listing, while navigating ongoing patent litigation and regulatory shifts in mercury and PFAS treatment markets.

ClearThink 1 Acquisition Corp. filed an S-1/A amendment detailing its 15 million unit IPO, trust account structure, and sponsor commitments for its SPAC offering.

Stardust Power Inc., a development-stage lithium refinery, has filed an S-1 registration statement for the resale of up to 2 million shares by B. Riley Principal Capital II, LLC, while acknowledging substantial doubt about its ability to continue as a going concern.

Clear Street Group Inc., a financial infrastructure technology company, filed an S-1/A for its initial public offering on Nasdaq, revealing significant revenue and net income growth for 2024 and the first nine months of 2025.

Solidion Technology, an advanced battery company, is offering up to 2 million shares and warrants to raise $11.3M, despite ongoing financial losses and substantial doubt about its ability to continue as a going concern.

ARKO Petroleum Corp. filed an S-1MEF to register an additional 702,777 shares of Class A common stock for its ongoing public offering.

Figure Technology Solutions, Inc. introduces Series A Blockchain Common Stock, convertible to Class A Common Stock, to trade on its Alternative Trading System (ATS) with strict KYC requirements.

HCW Biologics Inc. is offering up to $10 million in common stock and pre-funded warrants to fund its clinical development and operations, while navigating significant financial losses and ongoing legal and regulatory challenges.

zSpace, a provider of augmented and virtual reality educational technology, files an S-1 registration statement for the resale of up to 12.5 million common shares by selling stockholders and seeks to raise up to $24.4 million in additional capital.

Shuttle Pharmaceuticals Holdings, Inc. is offering up to 2,229,300 shares of common stock and pre-funded warrants to raise capital, signaling a strategic shift to AI-driven drug discovery following the acquisition of Molecule.ai and the discontinuance of its clinical trials.

Grayscale Sui Trust (SUI) filed an S-1/A, detailing its planned conversion to a staking ETF and listing on NYSE Arca, while disclosing financial performance and significant risks.

T3 Defense Inc. (formerly Nukkleus Inc.) has completed a strategic transformation from financial technology to aerospace and defense, marked by several acquisitions and a significant capital raise.

Envoy Medical, Inc. has filed an S-1MEF registration statement to offer an additional $13,437,500 in common stock and various warrants.

Clear Street Group Inc. filed an S-1/A for its initial public offering, targeting a $40.00-$44.00 per share price and highlighting significant revenue and net income growth, alongside strategic acquisitions and platform expansion.

Liminatus Pharma, a pre-clinical stage biopharmaceutical company, is offering up to 6.9 million shares and 10.3 million warrants to fund its CD47 immune checkpoint inhibitor development, despite significant losses and Nasdaq compliance issues.

Veri Medtech Holdings, Inc. filed an S-1/A registration statement for a firm commitment public offering of common stock, seeking capital while reporting significant net losses and a going concern doubt.

BioRestorative Therapies, Inc. filed an S-1/A amendment to include a Placement Agency Agreement and a revised filing fee table for its proposed public offering of securities.

Little West Holdings Inc. has filed an amended registration statement for its initial public offering, detailing underwriting terms, executive compensation, and existing financial agreements.

Rubber Leaf Inc. files for a 5 million share IPO at $4 per share, seeking Nasdaq listing after restructuring operations to Hong Kong and divesting its PRC subsidiary.

Brookline Capital Acquisition Corp II, a SPAC targeting healthcare and defense technology, filed an S-1/A for a $100 million IPO, emphasizing experienced management and a focus on established, profitable companies.

JOSS Realty REIT, Inc. filed an S-11/A for its initial public offering of 3 million shares, aiming to raise $10.75 million, despite recurring net losses and substantial doubt about its ability to continue as a going concern.

AIM ImmunoTech Inc. files an S-1/A for a rights offering to raise capital through the distribution of units comprising Series G Convertible Preferred Stock and Class G Common Stock Purchase Warrants to existing shareholders and warrant/option holders.

TV Channels Network Inc., a development-stage streaming company with no revenue, is launching an IPO at $4.00 per share despite auditors raising substantial doubt about its ability to continue as a going concern.

Karbon-X Corp. filed an S-1/A amendment to include an updated auditor's consent, which highlights substantial doubt about the company's ability to continue as a going concern.